We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA TO EASE PART 11 ENFORCEMENT IN CLINICAL TRIALS
FDA TO EASE PART 11 ENFORCEMENT IN CLINICAL TRIALS
September 30, 2004
The FDA will not, for the most part, enforce 21 CFR Part 11 rules related to computerized systems used in clinical trials, according to a draft guidance issued Sept. 29.